Artículo
Solvents to fragments to drugs: MD applications in drug design
Defelipe, Lucas Alfredo
; Arcon, Juan Pablo
; Modenutti, Carlos Pablo
; Marti, Marcelo Adrian
; Turjanski, Adrian
; Barril, Xavier
Fecha de publicación:
12/2018
Editorial:
Molecular Diversity Preservation International
Revista:
Molecules
ISSN:
1420-3049
Idioma:
Inglés
Tipo de recurso:
Artículo publicado
Clasificación temática:
Resumen
Simulations of molecular dynamics (MD) are playing an increasingly important role in structure-based drug discovery (SBDD). Here we review the use of MD for proteins in aqueous solvation, organic/aqueous mixed solvents (MDmix) and with small ligands, to the classic SBDD problems: Binding mode and binding free energy predictions. The simulation of proteins in their condensed state reveals solvent structures and preferential interaction sites (hot spots) on the protein surface. The information provided by water and its cosolvents can be used very effectively to understand protein ligand recognition and to improve the predictive capability of well-established methods such as molecular docking. The application of MD simulations to the study of the association of proteins with drug-like compounds is currently only possible for specific cases, as it remains computationally very expensive and labor intensive. MDmix simulations on the other hand, can be used systematically to address some of the common tasks in SBDD. With the advent of new tools and faster computers we expect to see an increase in the application of mixed solvent MD simulations to a plethora of protein targets to identify new drug candidates.
Archivos asociados
Licencia
Identificadores
Colecciones
Articulos(IQUIBICEN)
Articulos de INSTITUTO DE QUIMICA BIOLOGICA DE LA FACULTAD DE CS. EXACTAS Y NATURALES
Articulos de INSTITUTO DE QUIMICA BIOLOGICA DE LA FACULTAD DE CS. EXACTAS Y NATURALES
Citación
Defelipe, Lucas Alfredo; Arcon, Juan Pablo; Modenutti, Carlos Pablo; Marti, Marcelo Adrian; Turjanski, Adrian; et al.; Solvents to fragments to drugs: MD applications in drug design; Molecular Diversity Preservation International; Molecules; 23; 12; 12-2018; 1-14
Compartir
Altmétricas